Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma
Pathobiology · 2025
DOI: 10.1159/000544933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, 2025. Verfasst von Marina Pérez-Capó und 8 weiteren Autor:innen. Beteiligte Einrichtung: Group of Advanced Therapies and Biomarkers in Clinical Oncology, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain, marina.per…. Hauptthemen laut MEDLINE: Sarcoma, Wnt Signaling Pathway. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Introduction
Soft tissue sarcomas (STSs) are a group of rare malignancies with limited treatment options and a persistent lack of effective therapies. Despite the heterogeneous nature of STS, the canonical WNT/β-catenin signalling pathway has been associated with sarcomagenesis and also with the initiation and progression of other cancers.
Methods
Eight patient-derived primary cultures representing different STS histological subtypes were characterized by immunohisto(cyto)chemistry, WNT/β-catenin activation and next-generation sequencing.
Results
Elevated levels of active phospho-β-catenin and its nuclear localization were found in all STS primary cultures, with heterogeneous downstream WNT signalling activation. Genomic analysis of matched STS tumours identified pathogenic or likely pathogenic genetic variants in crucial signalling pathways, including WNT, DNA damage repair, and PI3K/AKT/mTOR-MAPK pathways. Interestingly, 50% of STS tumours studied carried genetic variants in PIK3CA and PTEN genes with potential clinical significance, listed as predictive biomarkers of response to specific drugs (FDA level 3).
Conclusions
This study provides valuable insights into WNT signalling vulnerabilities in STS, offering a foundation for the development of targeted therapeutic strategies and the identification of potential biomarkers for personalized treatment approaches in this challenging group of malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group of Advanced Therapies and Biomarkers in Clinical Oncology, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain, marina.perez@ssib.es.
- Research Institute of Health Sciences (IUNICS), University of the Balearic Islands, Palma, Spain, marina.perez@ssib.es.
- Medical Oncology Department, Son Espases University Hospital, Palma, Spain, marina.perez@ssib.es.
- Group of Advanced Therapies and Biomarkers in Clinical Oncology, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
- Research Institute of Health Sciences (IUNICS), University of the Balearic Islands, Palma, Spain.
- Medical Oncology Department, Son Espases University Hospital, Palma, Spain.
Zitieren
APA
Pérez-Capó, M., Martinez-Font, E., Prados, E., Ramos, R., Sánchez Morillas, R., Martorell, M. R., Vögler, O., Alemany, R., & Obrador-Hevia, A. (2025). Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma. Pathobiology. https://doi.org/10.1159/000544933
Vancouver
Pérez-Capó M, Martinez-Font E, Prados E, Ramos R, Sánchez Morillas R, Martorell MR, et al. Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma. Pathobiology. 2025. doi:10.1159/000544933
BibTeX
@article{PrezCap2025,
author = {Pérez-Capó, Marina and Martinez-Font, Esther and Prados, Elena and Ramos, Rafael and Sánchez Morillas, Raúl and Martorell, Maria Rosa and Vögler, Oliver and Alemany, Regina and Obrador-Hevia, Antònia},
title = {Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma},
journal = {Pathobiology},
year = {2025},
doi = {10.1159/000544933}
}
EUVIMED